HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1786137Generated: October 31, 2026
3,4-Dichlorobenzaldehyde → HCID 135463504, compound
https://huagongshe.com/reaction/1786137
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 3,4-Dichlorobenzaldehyde | HCID 22710 | — |
| Reactant | HCID 13794941 | HCID 13794941 | — |
| Reactant | HCID 178418690 | HCID 178418690 | — |
| Catalyst | Piperidine | HCID 8082 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 135463504 | HCID 135463504 | — |
Reaction Steps
1-(4-Fluorophenylsulfonyl)propan-2-one (150 mg, 0.69 mmol), 3-methyl-1H-pyrazol-5-amine (67 mg, 0.69 mmol) and 3,4-dichlorobenzaldehyde (121 mg, 0.69 mmol) were dissolved in THF (5 mL), to which was added a catalytic amount of piperidine (3 drops). The reaction in a sealed tube was stirred at 70° C. for about 48 hrs. After cooling to rt., solvent was removed and crude product was purified by HPLC (acetonitrile-water, 5% to 95% gradient) to provide pure Step B product 7-(3,4-dichlorophenyl)-6-(4-fluorophenylsulfonyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-a]pyrimidine as a solid. LC-MS found: (M+1)+=452.17. The two enantiomers were readily separated on Chiral PAK AS using 15% EtOH-MeOH in heptane.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07507730B2 |
|---|
| Source dataset | uspto-grants-2009_03 |
|---|
| ORD ID | ord-c935895953894e70b1c274db851ad23e |
|---|
| Source note | uspto-grants-2009_03 |
|---|